Crossref
The Economics Of Orphan Blockbuster Drug Development
Health Affairs · 01.08.2026 · 45 (8) · 838-845
DOI: 10.1377/hlthaff.2026.00209 ↗Kurz gefasst
Fachartikel in der Zeitschrift Health Affairs, erschienen am 01.08.2026. Verfasst von Jennifer C Chen und 2 weiteren Autor:innen. Beteiligte Einrichtung: Jennifer C. Chen, Verdant Research, New York, New York. Hauptthemen laut MEDLINE: Orphan Drug Production, Drug Costs, Drug Development, Medicare. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Orphan Drug ProductionDrug CostsDrug DevelopmentMedicareUnited StatesHumans
Autor:innen und Institutionen
- Jennifer C. Chen, Verdant Research, New York, New York.
- Chris Madsen, Verdant Research, Victoria, British Columbia, Canada.
- Anna Kaltenboeck (Anna@verdant-research.com), Verdant Research, Oakton, Virginia.
Zitieren
APA
Chen, J. C., Madsen, C., & Kaltenboeck, A. (2026). The Economics Of Orphan Blockbuster Drug Development. Health Affairs, 45(8), 838-845. https://doi.org/10.1377/hlthaff.2026.00209
Vancouver
Chen JC, Madsen C, Kaltenboeck A. The Economics Of Orphan Blockbuster Drug Development. Health Affairs. 2026;45(8):838-845. doi:10.1377/hlthaff.2026.00209
BibTeX
@article{Chen2026,
author = {Chen, Jennifer C and Madsen, Chris and Kaltenboeck, Anna},
title = {The Economics Of Orphan Blockbuster Drug Development},
journal = {Health Affairs},
year = {2026},
volume = {45},
number = {8},
pages = {838--845},
doi = {10.1377/hlthaff.2026.00209}
}
EUVIMED